{
  "78C.F": {
    "city": "Burton-on-Trent",
    "country": "United Kingdom",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Distribution",
    "long_name": "Clinigen Group plc",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "CLINIGEN GROUP PLC LS-001",
    "state": null,
    "summary": "Clinigen Group plc operates as a pharmaceutical and services company in the United Kingdom, rest of Europe, the United States, South Africa, Australia, and internationally. It operates through three segments: Commercial Medicines, Unlicensed Medicines, and Clinical Services. The Commercial Medicines segment acquires and licenses commercial medicines and then revitalises them, as well as provides access to licensed and branded generic medicines. The Unlicensed Medicines segment is involved in sourcing and supplying unlicensed medicines to hospital pharmacists and physicians for patients with a high unmet medical need. The Clinical Services segment packages, supplies, distributes, and manages comparator medicines and services to clinical trials and investigator initiated trials. It offers Cardioxane that protects the heart against the cardiotoxic effects of anthracyclines; Ethyol, which protect against the harmful effects of chemotherapy medications and radiation treatment; Proleukin for the treatment of kidney cancer; Imukin that is used in chronic granulomatous disease; Totect, a dexrazoxane product; Foscavir, an anti-virals which work by stopping viruses from multiplying in number; AZEDR for the treatment of adult and pediatric patients; and Savene, which is indicated in adults for the treatment of anthracycline extravasation. The company was incorporated in 2008 and is headquartered in Burton-on-Trent, the United Kingdom.",
    "website": "http://www.clinigengroup.com",
    "zipcode": "DE14 2WW"
  },
  "90K.F": {
    "city": "London",
    "country": "United Kingdom",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Distribution",
    "long_name": "Umuthi Healthcare Solutions Plc",
    "market": "dr_market",
    "market_cap": null,
    "sector": "Healthcare",
    "short_name": "UMUTHI HEALTH.SOL.LS-,001",
    "state": null,
    "summary": "Umuthi Healthcare Solutions Plc focuses on the distribution of pharmaceuticals and the provision of medical facilities in remote areas in South Africa. It supplies prescription and other medicines to medical practitioners and health centers. The company was incorporated in 2018 and is based in London, the United Kingdom.",
    "website": null,
    "zipcode": "W1W 8DH"
  },
  "CLIN.L": {
    "city": "Burton-on-Trent",
    "country": "United Kingdom",
    "currency": "GBp",
    "exchange": "LSE",
    "industry": "Medical Distribution",
    "long_name": "Clinigen Group plc",
    "market": "gb_market",
    "market_cap": null,
    "sector": "Healthcare",
    "short_name": "CLINIGEN GROUP PLC ORD 0.1P",
    "state": null,
    "summary": "Clinigen Group plc operates as a pharmaceutical and services company in the United Kingdom, rest of Europe, the United States, South Africa, Australia, and internationally. It operates through three segments: Commercial Medicines, Unlicensed Medicines, and Clinical Services. The Commercial Medicines segment acquires and licenses commercial medicines and then revitalises them, as well as provides access to licensed and branded generic medicines. The Unlicensed Medicines segment is involved in sourcing and supplying unlicensed medicines to hospital pharmacists and physicians for patients with a high unmet medical need. The Clinical Services segment packages, supplies, distributes, and manages comparator medicines and services to clinical trials and investigator initiated trials. It offers Cardioxane that protects the heart against the cardiotoxic effects of anthracyclines; Ethyol, which protect against the harmful effects of chemotherapy medications and radiation treatment; Proleukin for the treatment of kidney cancer; Imukin that is used in chronic granulomatous disease; Totect, a dexrazoxane product; Foscavir, an anti-virals which work by stopping viruses from multiplying in number; AZEDR for the treatment of adult and pediatric patients; and Savene, which is indicated in adults for the treatment of anthracycline extravasation. The company was incorporated in 2008 and is headquartered in Burton-on-Trent, the United Kingdom.",
    "website": "http://www.clinigengroup.com",
    "zipcode": "DE14 2WW"
  },
  "HHI.AX": {
    "city": "London",
    "country": "United Kingdom",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Distribution",
    "long_name": "Health House International Limited",
    "market": "au_market",
    "market_cap": null,
    "sector": "Healthcare",
    "short_name": "H HOUSE FPO",
    "state": null,
    "summary": "Health House Holdings Limited engages in the distribution of medicinal cannabis and pharmaceutical products. Health House Holdings Limited was formerly known as CLINICANN LIMITED and changed its name to Health House Holdings Limited in March 2019. The company was founded in 2014 and is based in London, United Kingdom.",
    "website": "http://www.healthhouse.uk",
    "zipcode": "EC4A 2DY"
  },
  "UHS.L": {
    "city": "London",
    "country": "United Kingdom",
    "currency": "GBp",
    "exchange": "LSE",
    "industry": "Medical Distribution",
    "long_name": "Umuthi Healthcare Solutions Plc",
    "market": "gb_market",
    "market_cap": null,
    "sector": "Healthcare",
    "short_name": "UMUTHI HEALTHCARE SOLUTIONS PLC",
    "state": null,
    "summary": "Umuthi Healthcare Solutions Plc focuses on the distribution of pharmaceuticals and the provision of medical facilities in remote areas in South Africa. It supplies prescription and other medicines to medical practitioners and health centers. The company was incorporated in 2018 and is based in London, the United Kingdom.",
    "website": null,
    "zipcode": "W1W 8DH"
  }
}
